Updated Safety and Efficacy Results of Abbv-383, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in a First-in-Human Phase 1 Study in Patients with Relapsed/Refractory Multiple MyelomaRavi Vij,Shaji Kunnathu Kumar, Anita D'Souza, John T. Mckay,Peter M. Voorhees,Alfred Chung,Sascha Alexander Tuchman,Neha Korde,Katja Weisel,Raphael Teipel, Orlando Bueno, Zhongling Feng, Tanya S. Rosenberg,Rajvineeth Kumar Pothacamury,Akshanth R. Polepally,Shane Lee,Ziyi Jin,Jeremy A. Ross, Aarif Ahsan,Chetasi Talati,Cesar RodriguezBLOOD（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
